{"DataElement":{"publicId":"2179618","version":"1","preferredName":"Agent Formulation Descriptive Text","preferredDefinition":"The text that describes the formulation of the agent used in the study.","longName":"AGT_FORM_DESCR_TXT","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"2179301","version":"1","preferredName":"Agent Formulation Descriptive Text","preferredDefinition":"Agent Formulation Descriptive Text","longName":"AGT_FORM_DESC_TXT","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2223333","version":"1","preferredName":"Agent","preferredDefinition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)","longName":"C1708","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F62B10F2-76A7-2830-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2839666","version":"1","preferredName":"Pharmaceutical Formulation Text","preferredDefinition":"The composition of a dosage form, including the characteristics of its raw materials and the operations required to process it.Formulation factors include chemical nature of the drug (ester, salt, complex, etc), drug solubility in water and organic solvents, particle size and surface area, type of dosage form (solution, suspension, capsule, tablet) and the excipients and processes used in the manufacturing of the drug delivery systems. The design of optimal drug delivery systems is thus an important part of providing an effective therapeutic.Official formulations for approved agents are presented in such books as the National Formulary and US Pharmacopeia. Whereas at one time, these were detailed and almost recipe-like, more recent entries may be limited to specifying the formula and imposing a standard limit for the active agent.:Text; the words of something written.","longName":"C42638:C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pharmaceutical Formulation","conceptCode":"C42638","definition":"The composition of a dosage form, including the characteristics of its raw materials and the operations required to process it.Formulation factors include chemical nature of the drug (ester, salt, complex, etc), drug solubility in water and organic solvents, particle size and surface area, type of dosage form (solution, suspension, capsule, tablet) and the excipients and processes used in the manufacturing of the drug delivery systems. The design of optimal drug delivery systems is thus an important part of providing an effective therapeutic.Official formulations for approved agents are presented in such books as the National Formulary and US Pharmacopeia. Whereas at one time, these were detailed and almost recipe-like, more recent entries may be limited to specifying the formula and imposing a standard limit for the active agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"631F3DA1-7158-FBA3-E040-BB89AD436893","latestVersionIndicator":"Yes","beginDate":"2009-02-17","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-02-17","modifiedBy":"ONEDATA","dateModified":"2009-02-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CF656CAF-955B-6628-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-12-26","endDate":null,"createdBy":"MAESKEB","dateCreated":"2003-12-26","modifiedBy":"REEVESD","dateModified":"2016-06-29","changeDescription":"Use caBIG NCIt based OC instead. - dw","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2179417","version":"1","preferredName":"Agent Formulation Descriptive Text","preferredDefinition":"All text that describes the formulation of the agent used in the study.","longName":"AGT_FORM_DESCR_TXT","context":"DCP","contextVersion":"1","type":"Enumerated","dataType":"ALPHANUMERIC","minLength":"5","maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Caplet","valueDescription":"Caplet","ValueMeaning":{"publicId":"2567673","version":"1","preferredName":"Caplet","longName":"2567673","preferredDefinition":"A dosing unit that contains medicinal substances in the form similar to a tablet enclosed within a tamper-resistant soluble container usually made from a suitable form of gelatin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Caplet Dosing Unit","conceptCode":"C64696","definition":"A dosing unit equal to the amount of active ingredient(s) contained in a caplet.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D566-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"REEVESD","dateModified":"2011-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP","id":"CFCBA97B-CD11-5D7B-E034-0003BA12F5E7","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Capsule","valueDescription":"Capsule","ValueMeaning":{"publicId":"2581082","version":"1","preferredName":"Capsule","longName":"2581082","preferredDefinition":"A solid contained within either a hard or soft soluble shell, usually prepared from gelatin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Capsule Dosage Form","conceptCode":"C25158","definition":"A solid contained within either a hard or soft soluble shell, usually prepared from gelatin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-09C7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"MAESKEB","dateModified":"2022-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP","id":"CFCBA97B-CD13-5D7B-E034-0003BA12F5E7","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Capsule/Liquid-filled","valueDescription":"Capsule/Liquid-filled","ValueMeaning":{"publicId":"2567674","version":"1","preferredName":"Capsule/Liquid-filled","longName":"2567674","preferredDefinition":"A solid dosage form in which the drug is enclosed within a soluble, gelatin shell which is plasticized by the addition of a polyol, such as sorbitol or glycerin, and is therefore of a somewhat thicker consistency than that of a hard shell capsule; typically, the active ingredients are dissolved or suspended in a liquid vehicle.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liquid Filled Capsule Dosage Form","conceptCode":"C42954","definition":"A capsule composed of liquid covered with an outer shell, which is usually prepared from gelatin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D567-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"MAESKEB","dateModified":"2013-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP","id":"CFCBA97B-CD15-5D7B-E034-0003BA12F5E7","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Capsule/Micronized Powder","valueDescription":"Capsule/Micronized Powder","ValueMeaning":{"publicId":"2567675","version":"1","preferredName":"Capsule/Micronized Powder","longName":"2567675v1.00","preferredDefinition":"A process to reduce a solid material to particles with an average size described in microns._A solid substance in the form of tiny loose particles; a solid that has been pulverized._A drug packaging type usually in a cylindrical shape with rounded ends. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid drug products.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Micronization","conceptCode":"C106177","definition":"A process to reduce a solid material to particles with an average size described in microns.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Powder","conceptCode":"C45302","definition":"A solid substance in the form of tiny loose particles; a solid that has been pulverized.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Capsule","conceptCode":"C92708","definition":"A drug packaging type usually in a cylindrical shape with rounded ends. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid drug products.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D568-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"CLOHNES","dateModified":"2023-06-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP","id":"CFCBA97B-CD17-5D7B-E034-0003BA12F5E7","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Cartridge","valueDescription":"Cartridge","ValueMeaning":{"publicId":"2567676","version":"1","preferredName":"Cartridge","longName":"2567676","preferredDefinition":"A dosing unit equal to the amount of active ingredient(s) contained in a cartridge.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cartridge Dosing Unit","conceptCode":"C48481","definition":"A dosing unit equal to the amount of active ingredient(s) contained in a cartridge.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D569-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"MAESKEB","dateModified":"2013-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP","id":"CFCBA97B-CD19-5D7B-E034-0003BA12F5E7","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Cream","valueDescription":"Cream","ValueMeaning":{"publicId":"2567677","version":"1","preferredName":"Cream","longName":"2567677","preferredDefinition":"A semisolid emulsion of either the oil-in-water or the water-in-oil type, ordinarily intended for topical use.|On-line Medical Dictionary\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cream Dosage Form","conceptCode":"C28944","definition":"A semi-solid composed of an emulsion of lipids, hydrocarbons, waxes, or polyols in water.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D56A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"REEVESD","dateModified":"2006-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP","id":"CFCBA97B-CD1B-5D7B-E034-0003BA12F5E7","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Depot","valueDescription":"Depot","ValueMeaning":{"publicId":"2567678","version":"1","preferredName":"Depot","longName":"2567678v1.00","preferredDefinition":"Parenteral sustained-release systems of microparticles, implants, or biodegradable polymer-excipients designed to release their active pharmaceutical ingredient over a prolonged period of time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Extended Release Depot Dosage Form","conceptCode":"C106178","definition":"Parenteral sustained-release systems of microparticles, implants, or biodegradable polymer-excipients designed to release their active pharmaceutical ingredient over a prolonged period of time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D56B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"CLOHNES","dateModified":"2023-06-27","changeDescription":null,"administrativeNotes":"6/27/23 Added concept for VM per cleanup efforts cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP","id":"CFCBA97B-CD1D-5D7B-E034-0003BA12F5E7","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Device","valueDescription":"Device","ValueMeaning":{"publicId":"2567679","version":"1","preferredName":"Device","longName":"2567679","preferredDefinition":"Any physical object that is useful for prevention, diagnosis, monitoring, or treatment of disease or other conditions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medical Device","conceptCode":"C16830","definition":"Any physical object that is useful for prevention, diagnosis, monitoring, or treatment of disease or other conditions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D56C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"MAESKEB","dateModified":"2013-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP","id":"CFCBA97B-CD1F-5D7B-E034-0003BA12F5E7","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Liquid","valueDescription":"Liquid","ValueMeaning":{"publicId":"2567331","version":"1","preferredName":"Liquid","longName":"2567331","preferredDefinition":"A substance in the fluid state of matter having no fixed shape but a fixed volume.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liquid","conceptCode":"C45298","definition":"A substance in the fluid state of matter having no fixed shape but a fixed volume.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D410-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"MAESKEB","dateModified":"2022-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP","id":"CFCBA97B-CD21-5D7B-E034-0003BA12F5E7","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Lotion","valueDescription":"Lotion","ValueMeaning":{"publicId":"2581083","version":"1","preferredName":"Lotion","longName":"2581083","preferredDefinition":"A liquid preparation for bathing the skin, or an injured or diseased part, either for a medicinal purpose, or for improving its appearance.|On-line Medical Dictionary\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lotion Dosage Form","conceptCode":"C29167","definition":"A semi-solid composed of an oil in water emulsion, with lower viscosity than cream or gel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-09C8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"REEVESD","dateModified":"2006-09-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP","id":"CFCBA97B-CD23-5D7B-E034-0003BA12F5E7","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Ointment","valueDescription":"Ointment","ValueMeaning":{"publicId":"2567680","version":"1","preferredName":"Ointment","longName":"2567680","preferredDefinition":"A semisolid preparation intended for external application to the skin or mucous membranes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ointment Dosage Form","conceptCode":"C42966","definition":"A semi-solid, viscous in texture, that may be composed of a variety of bases including hydrocarbons, emulsifiers or vegetable oils, and mixed with active and/or inert ingredient(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D56D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"MAESKEB","dateModified":"2013-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP","id":"CFCBA97B-CD25-5D7B-E034-0003BA12F5E7","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Powder","valueDescription":"Powder","ValueMeaning":{"publicId":"2567681","version":"1","preferredName":"Powder","longName":"2567681","preferredDefinition":"A solid substance in the form of tiny loose particles; a solid that has been pulverized.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Powder","conceptCode":"C45302","definition":"A solid substance in the form of tiny loose particles; a solid that has been pulverized.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D56E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"MAESKEB","dateModified":"2019-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP","id":"CFCBA97B-CD27-5D7B-E034-0003BA12F5E7","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Tablet","valueDescription":"Tablet","ValueMeaning":{"publicId":"2567682","version":"1","preferredName":"Tablet","longName":"2567682","preferredDefinition":"A solid dosage form containing medicinal substances with or without suitable diluents.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tablet Dosage Form","conceptCode":"C42998","definition":"A solid composed of a mixture of that active and/or inert ingredient(s) are pressed or compacted together, usually in the form of a relatively flat and round, square or oval shape.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D56F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"MAESKEB","dateModified":"2013-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP","id":"CFCBA97B-CD29-5D7B-E034-0003BA12F5E7","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Patch","valueDescription":"Patch","ValueMeaning":{"publicId":"2571184","version":"1","preferredName":"Patch","longName":"2571184","preferredDefinition":"A drug delivery system that contains an adhesive backing and that permits its ingredients to diffuse from some portion of it (e.g., the backing itself, a reservoir, the adhesive, or some other component) into the body from the external site where it is applied.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patch Dosage Form","conceptCode":"C42968","definition":"A solid composed of an impermeable occlusive backing and a formulation matrix in which the active and/or inert ingredient(s) are dissolved or dispersed; possibly includes an adhesive layer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E31D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-07-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-07-23","modifiedBy":"MAESKEB","dateModified":"2013-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F428C665-783F-2F56-E034-0003BA3F9857","beginDate":"2005-04-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-04-11","modifiedBy":"MAESKEB","dateModified":"2005-04-11","deletedIndicator":"No"},{"value":"Injection","valueDescription":"Injection","ValueMeaning":{"publicId":"2574364","version":"1","preferredName":"Injection","longName":"2574364","preferredDefinition":"A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Injectable Dosage Form","conceptCode":"C42946","definition":"A substance intended for injection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EF89-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-04-11","modifiedBy":"MAESKEB","dateModified":"2013-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F428C665-7840-2F56-E034-0003BA3F9857","beginDate":"2005-04-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-04-11","modifiedBy":"MAESKEB","dateModified":"2005-04-11","deletedIndicator":"No"},{"value":"Sachet","valueDescription":"Sachet Dosing Unit","ValueMeaning":{"publicId":"2735738","version":"1","preferredName":"Sachet Dosing Unit","longName":"2735738","preferredDefinition":"A dosing unit that contains a solid pharmaceutical preparation in the form of a small packet or bag made from a flexible, often porous material.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sachet Dosing Unit","conceptCode":"C71324","definition":"A dosing unit equal to the amount of active ingredient(s) contained in a sachet.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"48BA78D8-84DF-5CAF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"MAESKEB","dateCreated":"2008-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B308EC66-EC02-D515-E040-BB89AD435721","beginDate":"2011-12-01","endDate":null,"createdBy":"MAESKEB","dateCreated":"2011-12-01","modifiedBy":"ONEDATA","dateModified":"2011-12-01","deletedIndicator":"No"},{"value":"Sprinkles","valueDescription":null,"ValueMeaning":{"publicId":"12311431","version":"1","preferredName":"Sprinkles","longName":"12311431v1.00","preferredDefinition":"A capsule composed active and/or inert ingredient(s) of as small pellet-like granules. The capsule is intended to be broken open, facilitating the scattering of the granules into soft foods, although it may also be swallowed whole.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sprinkle Capsule Dosage Form","conceptCode":"C68946","definition":"A capsule composed active and/or inert ingredient(s) of as small pellet-like granules. The capsule is intended to be broken open, facilitating the scattering of the granules into soft foods, although it may also be swallowed whole.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1D93AA6-0899-5A85-E053-731AD00A97B6","latestVersionIndicator":"Yes","beginDate":"2023-01-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-01-09","modifiedBy":"KUMMEROA","dateModified":"2023-01-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F1D93AA6-089A-5A85-E053-731AD00A97B6","beginDate":"2023-01-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-01-09","modifiedBy":"KUMMEROA","dateModified":"2023-01-09","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234203","version":"1","preferredName":"Text","preferredDefinition":"Text; the words of something written.","longName":"C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F89B-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFCBA97B-C92C-5D7B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"KUMMEROA","dateModified":"2023-01-09","changeDescription":null,"administrativeNotes":"2023.1.9 PV added per ticket request CADSR0001884. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2179692","version":"1","longName":"TYPE OF CATEGORY","context":"DCP","ClassificationSchemeItems":[{"publicId":"2812969","version":"1","longName":"CSAERS Adverse Events","context":"DCP"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3449457","version":"1","longName":"Study Agent Administration","context":"NCIP"},{"publicId":"2867242","version":"1","longName":"Concomitant Medication CRF","context":"NCIP"}]},{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"3303197","version":"1","longName":"Phase 1/Pilot Consortium","context":"COG"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104941","version":"1","longName":"GOG-0281","context":"NRG"},{"publicId":"10000705","version":"1","longName":"GOG-0281","context":"NRG"},{"publicId":"4104901","version":"1","longName":"GOG-0286B","context":"NRG"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000582","version":"1","longName":"Study Agent Administration","context":"NCI Standards"},{"publicId":"5635301","version":"1","longName":"Concomitant Medication","context":"NCI Standards"}]}],"AlternateNames":[{"name":"CCR","type":"USED_BY","context":"CCR"},{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"CTEP","type":"USED_BY","context":"CTEP"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AGT_FORM_DESCR_TXT","type":"USED_BY","context":"CTEP"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"},{"name":"AGT_FORM_DESCR_TXT","type":"USED_BY","context":"NRG"},{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"Formulation","type":"Preferred Question Text","description":"Formulation","url":null,"context":"DCP"},{"name":"COG_CRF_TXET_1","type":"Alternate Question Text","description":"Formulation used during this reporting period","url":null,"context":"CTEP"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Formulation of Lorlatinib administered:","url":null,"context":"COG"}],"origin":"CSAERS:Chemoprevention Serious Adverse Event System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"CFCBA97B-D287-5D7B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"FEIBUSHL","dateModified":"2022-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}